(NOVL) Novell Reports Mixed Results
Novell, Inc. (NOVL), a leading technology software company reported mixed third quarter results with revenue slightly below expectations and adjusted EPS marginally over. Revenue of $216.1 million in...
View Article(AZN) AstraZeneca’s Brilinta Drug Stomps Plavix
AstraZeneca (AZN) recently said that results from a phase III head-to-head trial showed that its Brilinta (ticagrelor) achieved greater efficacy in the primary endpoint, reduction of cardiovascular...
View Article
More Pages to Explore .....
